ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1196

Associations of Biological Sex with Interstitial Lung Disease in Patients with Rheumatoid Arthritis Are Independent of Other Known Risk Factors

Austin Wheeler1, Gail Kerr2, Ilona Jileaeva3, Asha Krishna4, Bryant England1, Harlan Sayles1, Geoffrey Thiele1, Jill Poole1, Alison Petro1 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2Washington DC VA Medical Center, Washington, DC, 3Howard University Hospital, Washington, DC, 4Washington, D.C. VAMC, Washington, DC

Meeting: ACR Convergence 2020

Keywords: gender, interstitial lung disease, race/ethnicity, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: RA – Diagnosis, Manifestations, & Outcomes Poster III: Cardiopulmonary Aspects

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Extra-articular manifestations of rheumatoid arthritis (RA), such as nodules and interstitial lung disease (ILD), portend poor outcomes and are more common in men than in women. Whether differences in the risk of RA-ILD between men and women are related to biologic sex or to other known risk factors such as cigarette smoking or increased RA disease activity, which might differ by sex, is unknown. The purpose of this cross-sectional study was to evaluate sex differences in the prevalence of extra-articular manifestations in RA, accounting for known factors that might confound these associations.

Methods: Participants were enrollees in a multicenter, longitudinal observational cohort of US Veterans with RA. A total of 2,691 participants were studied. Baseline demographic, clinical, and treatment variables were collected and compared between men and women using either Student’s t-tests or chi-square tests. Participants were categorized by the presence or absence of subcutaneous nodules, chronic lung disease (ILD or chronic obstructive pulmonary disease [COPD] vs. ILD alone) and ILD. Chronic lung diseases were determined from diagnostic codes recorded by treating rheumatologists at enrollment. Associations of sex (male vs. female) with each extra-articular manifestation was assessed using separate multivariable logistic regression models. Covariates included; Model 1: age; Model 2: age, race, body mass index (BMI); Model 3: age, race, BMI, measures of disease activity and RA treatments; Model 4: all aforementioned covariates and HLA-DRB1 shared epitope status, smoking history, and anti-citrullinated protein antibody (ACPA) status.

Results: Baseline characteristics of men and women with RA are shown in (Table 1). Compared to women with RA, men were older, more likely to be Caucasian, smokers, and had greater disease activity, higher autoantibody concentrations and more comorbidity. Men more often had nodules (28% vs. 19%, p = 0.001), COPD (17% vs. 10%, p = 0.004) and ILD (4.7% vs. 1.0%, p = 0.002).  In hierarchical regression models, these sex differences all remained following adjustment for age (Table 2, Model 1).  With progressive adjustments (Table 2, Models 2 to 4), associations between sex and nodules or chronic lung disease were attenuated and no longer significant.  In contrast, associations of male sex with ILD alone remained following progressive adjustments. Results were unchanged in more parsimonious models including only age, smoking, disease activity and ACPA positivity as covariates (data not shown).

Conclusion: The association between subcutaneous nodules and chronic lung disease with male sex in RA is confounded by other factors, rather than representing true differences arising from biologic sex.  In contrast, associations of biologic sex with RA-ILD persist even after adjustment for multiple confounders, including cigarette smoking, RA disease activity and/or severity, and treatments. Our findings suggest that real sex differences drive the marked differences observed in RA-ILD prevalence in men compared to women. Further exploration into mechanisms underpinning the predisposition to RA-ILD among men is needed as this could inform future preventive and/or treatment strategies.

* RAPID-3: Routine Assessment of Patient Index Data; MD-HAQ: Multidimensional Health Assessment Questionnaire; RDCI: rheumatic disease comorbidity index; ILD: interstitial lung disease; COPD: chronic obstructive pulmonary disease; HLA-SE: human leukocyte antigen shared epitope; RF: rheumatoid factor; ACPA: anti-citrullinated peptide antibodies

Covariates: Model 1 = age Model 2 = age, race, BMI Model 3 = age, race, BMI, disease duration, RAPID-3, MTX, prednisone, biologic therapy Model 4 = age, sex, race, BMI, disease duration, RAPID-3, MTX, prednisone, biologic therapy, HLA-DRB1 (pos vs. neg), smoking (ever vs. never), ACPA positivity


Disclosure: A. Wheeler, None; G. Kerr, Novartis, 1, BMS, 1, 2, Gilead, 1, Regeneron, 1, Janssen, 1; I. Jileaeva, None; A. Krishna, None; B. England, None; H. Sayles, None; G. Thiele, None; J. Poole, None; A. Petro, None; T. Mikuls, Horizon Therapeutics, 2.

To cite this abstract in AMA style:

Wheeler A, Kerr G, Jileaeva I, Krishna A, England B, Sayles H, Thiele G, Poole J, Petro A, Mikuls T. Associations of Biological Sex with Interstitial Lung Disease in Patients with Rheumatoid Arthritis Are Independent of Other Known Risk Factors [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/associations-of-biological-sex-with-interstitial-lung-disease-in-patients-with-rheumatoid-arthritis-are-independent-of-other-known-risk-factors/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/associations-of-biological-sex-with-interstitial-lung-disease-in-patients-with-rheumatoid-arthritis-are-independent-of-other-known-risk-factors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology